Search results
CRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo Finance· 2 years agoCRISPR Therapeutics AG (CRSP) possesses the right combination of the two key ingredients for a...
CRISPR Therapeutics AG (CRSP) Reports Q3 Loss, Lags Revenue Estimates
Zacks via Yahoo Finance· 2 years agoCRISPR Therapeutics AG (CRSP) delivered earnings and revenue surprises of 2.61% and 97.33%,...
CRISPR Therapeutics AG (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 8 months agoA month has gone by since the last earnings report for CRISPR Therapeutics AG (CRSP). Shares have...
What Makes CRISPR Therapeutics AG (CRSP) a New Buy Stock
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics AG (CRSP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing...
CRISPR Therapeutics AG (CRSP) Gains But Lags Market: What You Should Know
Zacks via Yahoo Finance· 1 year agoCRISPR Therapeutics AG (CRSP) closed at $49.13 in the latest trading session, marking a +0.99% move...
CRISPR Therapeutics AG (CRSP) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Zacks via Yahoo Finance· 2 months agoCRISPR Therapeutics AG (CRSP) closed at $71.08 in the latest trading session, marking a -0.74% move...